Idebenone: study protocols

4 study groups say how much Idebenone participants took a day. These are the doses the studies gave. They are not a recommendation.

Fewer than 5 study groups in one unit match, too few to draw the chart.

Commonly used together

None of these 4 study groups took Idebenone with anything else.

4 study groups

Study
Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study 1998 · placebo for 12 months, followed by idebenone 90 mg tid for another 12 months · Patients with mild to moderate dementia of the Alzheimer type	270 mg	1 year	153
Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study 1998 · idebenone 120 mg tid for 24 months · Patients with mild to moderate dementia of the Alzheimer type	360 mg	2 years	149
Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study 1998 · idebenone 90 mg tid for 24 months · Patients with mild to moderate dementia of the Alzheimer type	270 mg	2 years	148
Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial 2015 · idebenone · Patients aged 10–18 years with Duchenne muscular dystrophy who were not taking concomitant glucocorticoids	900 mg	52 weeks	32